| Target Price | $275.40 |
| Price | $208.93 |
| Potential |
31.81%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target Steris 2027 .
The average Steris target price is $275.40.
This is
31.81%
register free of charge
$300.30
43.73%
register free of charge
$234.32
12.15%
register free of charge
|
|
| A rating was issued by 16 analysts: 11 Analysts recommend Steris to buy, 5 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Steris stock has an average upside potential 2027 of
31.81%
register free of charge
|
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion $ | 5.94 | 6.44 |
| 8.73% | 8.43% | |
| EBITDA Margin | 26.93% | 28.78% |
| 1.53% | 6.87% | |
| Net Margin | 13.18% | 17.09% |
| 17.06% | 29.67% |
13 Analysts have issued a sales forecast Steris 2027 . The average Steris sales estimate is
This results in the following potential growth metrics:
10 Analysts have issued an Steris EBITDA forecast 2027. The average Steris EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Steris Analysts have issued a net profit forecast 2027. The average Steris net profit estimate is
This results in the following potential growth metrics and future Net Margins:
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share $ | 7.93 | 11.28 |
| 27.90% | 42.24% | |
| P/E | 18.50 | |
| EV/Sales | 3.38 |
13 Analysts have issued a Steris forecast for earnings per share. The average Steris EPS is
This results in the following potential growth metrics and future valuations:
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Piper Sandler |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 07 2026 |
| UBS |
Locked
➜
Locked
|
Locked | Jul 28 2026 |
| Keybanc |
Locked
➜
Locked
|
Locked | May 13 2026 |
| Keybanc |
Locked
➜
Locked
|
Locked | Jul 22 2025 |
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Jul 15 2025 |
| Jefferies |
Locked
➜
Locked
|
Locked | May 29 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Piper Sandler:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 07 2026 |
|
Locked
UBS:
Locked
➜
Locked
|
Jul 28 2026 |
|
Locked
Keybanc:
Locked
➜
Locked
|
May 13 2026 |
|
Locked
Keybanc:
Locked
➜
Locked
|
Jul 22 2025 |
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Jul 15 2025 |
|
Locked
Jefferies:
Locked
➜
Locked
|
May 29 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


